FFO
TNYA icon

Fortitude Family Office’s Tenaya Therapeutics TNYA Stock Holding History

Fortitude Family Office’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-616
Closed -$427 – 2375
2026
Q1 		$427 Buy
+616
New +$455 ﹤0.01% 1784

Other funds holding TNYA

MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
EL
EWA LLC Pittsbugh, Pennsylvania $548M AUM 35.14% 1-Year Est. Return
VWA
VSM Wealth Advisory Hunt Valley, Maryland $376M AUM 21.56% 1-Year Est. Return
PWP
Parkwoods Wealth Partners Syracuse, New York $622M AUM 24.36% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

Fortitude Family Office's TNYA Position: Q2 2026 in Review

Fortitude Family Office sold out of Tenaya Therapeutics (TNYA) in Q2 2026, closing a stake of 616 shares — an estimated $427 sold.

Fortitude Family Office first reported a position in TNYA in Q1 2026 and held it in 1 quarter. The position peaked at $427 in Q1 2026. 18 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Fortitude Family Office reported no remaining Tenaya Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Fortitude Family Office sold 616 Tenaya Therapeutics shares in Q2 2026, an estimated $427.
  • Fortitude Family Office first reported a position in Tenaya Therapeutics in Q1 2026 and held it in 1 quarter.
  • Fortitude Family Office's Tenaya Therapeutics position peaked at $427 in Q1 2026.
  • 18 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.